Safe Study

Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials BMJ 1998;317: 235–240.

Offringa M . Excess mortality after human albumin administration. Clinical and pathophysiological evidence suggests albumin is harmful. BMJ 1998;317: 223–4.

Soni N . Validity of review methods must be assessed. BMJ 1998;317: 883–4.

Report of the Albumin Expert Working Party of the Committee on Safety of Medicines. http://www.mca.gov.uk/inforesources/publications/albumin1.htm.

Chalmers I . I would not want an albumin transfusion. BMJ 1998;317: 885.

Roberts I Edwards P McLelland B . More on albumin: Use of human albumin in UK fell substantially when systemic review was published. BMJ 1999;318: 1214–5.

Wilkes M Navickis R . Patient survival after human albumin administration: a meta-analysis of randomized controlled trials. Ann Intern Med 2001;135: 149–64.

The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350: 2247–56.

Doig GS . Interpreting and using clinical trials. Evidence based Critical Care Medicine. In: Critical Care Clinics 1998;14 (3): 513–24. WB Saunders. Philadelphia.

Rowan K Kerr JH Major E McPherson K Short A Vassey MP . Intensive Care Society's APACHE II study in Britain and Ireland – I: Variations in case mix of adult admissions to general intensive care units and impact on outcome. BMJ 1993;307: 972–7.